Dural Puncture Epidural Versus Combined Spinal Epidural With Epidural Volume Extension in Labor Analgesia

February 7, 2022 updated by: Muhammed E Aydin, Ataturk University

The Effects of Dural Puncture Epidural Versus Combined Spinal Epidural With Epidural Volume Extension Techniques on Birth Variables in Labor Analgesia

Labor is the process where the cervix is prepared to allow the baby to pass from the uterine cavity to the outside world. In the ordinary course, it ends with spontaneous or instrumental vaginal delivery or cesarean section. Traditionally, the first stage in which the cervix is passively dilated in response to uterine contractions consists of the second stage in which the mother passes the baby through the vagina and the third stage, the exit of the placenta.

In the first stage of labor, pain is caused by uterine contractions and pressure on the cervix. Pain is transmitted through the T10-L2 spinal nerves and is felt in the abdominal wall, waist, hips, or thighs. In the second stage, pain from the vagina and perineum is added to uterine pain. This pain is transmitted by the pudendal nerves through the S2-4 nerve roots.

In this study, we aimed to investigate the effects of dural puncture epidural analgesia versus combined spinal-epidural analgesia with epidural volume extension on labor variables.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yakutiye
      • Erzurum, Yakutiye, Turkey, 25100
        • Ataturk University
      • Erzurum, Yakutiye, Turkey, 25100
        • Erzurum Regional Training Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • ASA I and II parturients
  • Pregnant patients in active labor
  • active labor with cervical dilation < 5cm
  • 37-42 weeks of gestational age
  • Pregnant women between the ages of 18 and 45

Exclusion Criteria:

  • Patients who do not want to participate voluntarily in the study
  • Pregnant women outside the age range of 18 - 45
  • Pregnants other than Nullipar
  • Patients with allergic reactions to anesthesia and analgesia drugs to be used
  • Severe systemic disease (kidney, liver, pulmonary, endocrine, cardiac)
  • Gestational comorbidity (preeclampsia, eclampsia, diabetes mellitus, etc.)
  • Substance abuse history
  • Chronic pain history
  • Psychiatric problems and communication difficulties
  • BMI> 35 kg / m2
  • Failure in neuraxial interventions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Dural puncture epidural
2 µg/ml fentanyl + %0,125 bupivacaine (20 ml) to epidural
2 µg/ml fentanyl + %0,125 bupivacaine (20 ml) to epidural
Active Comparator: Combined spinal-epidural with epidural volume extension
10 µg fentanyl + 2 mg bupivacaine to intrathecal 7.4 ml saline volume to epidural
10 µg fentanyl + 2 mg bupivacaine to intrathecal 7.4 ml saline volume to epidural

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First Epidural top-up time
Time Frame: First 24 hours
Time elapsed between the end of local anesthetic injection and the return of pain >4 on the NPRS.
First 24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sacral analgesia time
Time Frame: First 24 hours
Blockade of the S2 dermatome
First 24 hours
Performance time
Time Frame: First 24 hours
interval between skin disinfection and epidural catheter fixation to the skin
First 24 hours
Incidence of Side Effect
Time Frame: First 24 hours
maternal motor block, hypotension, pruritis, headache and fetal bradycardia
First 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Muhammed En Aydin, Ataturk University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

February 1, 2021

Study Completion (Actual)

February 7, 2021

Study Registration Dates

First Submitted

January 16, 2020

First Submitted That Met QC Criteria

January 16, 2020

First Posted (Actual)

January 21, 2020

Study Record Updates

Last Update Posted (Actual)

February 8, 2022

Last Update Submitted That Met QC Criteria

February 7, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ATATURKLABOR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Pain

Clinical Trials on Epidural

Subscribe